Genprex

Genprex Non-Current Assets

The Non-Current Assets of Genprex (GNPX) as of Oct 18, 2026 is -8.36 M USD. In the previous year, Non-Current Assets was -30,566.00 USD — a change of 27,240.12% (lower).

Non-Current Assets

-8.36 MUSD

YoY

27,240.12%

Last updated:

Non-Current Assets of Genprex is 2025 -8.36 M USD. Non-Current Assets of Genprex was 2024 -30,566.00 USD. It decreases by 27,240.12% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genprex Stock analysis

What does Genprex do? Genprex Inc is a clinical-stage gene therapy company headquartered in Austin, Texas, operating in the Health Care sector. Listed on March 29, 2018, the firm employs approximately 13 people and focuses on developing potentially life-changing technologies for patients with cancer and diabetes. Its lead product candidate, Oncoprex, is an immunogene therapy utilizing a tumor suppressor gene licensed from The University of Texas MD Anderson Cancer Center. This therapy is currently being developed for non-small cell lung cancer, often in combination with targeted or immunotherapies. Additionally, Genprex is researching a pre-clinical gene therapy licensed from the University of Pittsburgh, which aims to cure type 1 and type 2 diabetes. Genprex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genprex stock

Non-Current Assets of Genprex is -8.36 M USD in 2025.

Non-Current Assets of Genprex changed from -30,566.00 USD to -8.36 M USD, representing a 27,240.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Non-Current Assets Genprex since 2006 – with annual values, charts, and detailed analysis.

Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.

Non-Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's Genprex historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Genprex

All Key Metrics — Genprex